Nosa Med AB
Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, rest of Europe, the United States, Canada, and internationally. The company offers NOSA allergy filter that filters airborne allergens, such as pollen, pet dander, dust, and mold; NOSA smell training, a smell training medical device to improve the sense of smell for individuals … Read more
Nosa Med AB (NOSA) - Total Assets
Latest total assets as of September 2025: Skr67.06 Million SEK
Based on the latest financial reports, Nosa Med AB (NOSA) holds total assets worth Skr67.06 Million SEK as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nosa Med AB - Total Assets Trend (2016–2024)
This chart illustrates how Nosa Med AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nosa Med AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Nosa Med AB's total assets of Skr67.06 Million consist of 61.2% current assets and 38.8% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 20.9% |
| Accounts Receivable | Skr3.77 Million | 18.2% |
| Inventory | Skr4.13 Million | 20.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr1.39 Million | 6.7% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Nosa Med AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nosa Med AB's current assets represent 61.2% of total assets in 2024, an increase from 25.0% in 2016.
- Cash Position: Cash and equivalents constituted 20.9% of total assets in 2024, down from 24.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 60.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 20.0% of total assets.
Nosa Med AB Competitors by Total Assets
Key competitors of Nosa Med AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Nosa Med AB - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Nosa Med AB generates 0.78x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nosa Med AB is currently not profitable relative to its asset base.
Nosa Med AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.40 | 4.26 | 2.59 |
| Quick Ratio | 1.97 | 3.54 | 2.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr16.67 Million | Skr 12.63 Million | Skr 20.89 Million |
Nosa Med AB - Advanced Valuation Insights
This section examines the relationship between Nosa Med AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.88 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | -37.4% |
| Total Assets | Skr20.70 Million |
| Market Capitalization | $10.96 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nosa Med AB's assets below their book value (0.53 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Nosa Med AB's assets decreased by 37.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nosa Med AB (2016–2024)
The table below shows the annual total assets of Nosa Med AB from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr20.70 Million | -37.44% |
| 2023-12-31 | Skr33.08 Million | +52.67% |
| 2022-12-31 | Skr21.67 Million | -45.95% |
| 2021-12-31 | Skr40.09 Million | -65.52% |
| 2020-12-31 | Skr116.25 Million | -42.91% |
| 2019-12-31 | Skr203.64 Million | -5.10% |
| 2018-12-31 | Skr214.60 Million | +7.45% |
| 2017-12-31 | Skr199.72 Million | +16.34% |
| 2016-12-31 | Skr171.66 Million | -- |